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Abstract
Purpose To analyze foveal avascular zone (FAZ) dimensions
and symmetry in patients with diabetic retinopathy (DR) com-
pared to healthy controls using optical coherence tomography
angiography (OCT angiography).
Methods OCT angiography was performed via an Avanti®
RTVue 100 XR OCT system (Optovue, Inc., Fremont, CA,
USA) in patients with diabetes mellitus (DM) and healthy
adults. A frame centered on the fovea was used for FAZ mea-
surements. The borders of the superficial vascular layer were
defined as 3 μm below the internal limiting membrane (ILM)
and 15 μm below the inner plexiform layer (IPL), and for the
deep vascular layer as15 μm and 70 μm below the IPL, re-
spectively. Angles of maximum FAZ diameter were measured
in all eyes by two graders.
Results In healthy eyes (N=25), the FAZ surrounding vascu-
lar arcades were intact, showing a vertical or horizontal oval
symmetrical formation with a maximum diameter usually on
the horizontal or vertical axis. Diabetic eyes (N=29) presented
with disintegrity of the vascular arcades, resulting in an en-
larged FAZ. In the superficial layer, the mean horizontal FAZ
diameter was significantly larger in the DR group (753 μm
±272 μm) than in the control group (573 μm ±177 μm, p=
0.029). The difference was even more pronounced in the deep
layer, with a mean value of 659 μm ±194 μm in the control
group and 1009 μm ±342 μm in the DR group (p=0.001).
Furthermore, in the superficial layer, the angle of the maxi-
mum FAZ diameter was 0° (±15°) or 90° (±15°) in 72.0 % of
healthy eyes. In eyes with DR, the angle was 0° (±15°) or 90°
(±15°) in only 6.9 % of cases, due to the irregular configura-
tion of the FAZ.
Conclusions OCT angiography is capable of imaging retinal
vasculature without dye injection. Our data suggest that it can
detect disintegrity of the vascular arcades surrounding the
FAZ, thus differentiating DM from healthy eyes. Vascular
abnormalities were more pronounced in the deep vascular
layer.
Keywords Optical coherence tomography angiography .
Foveal avascular zone . Diabetic retinopathy
Introduction
Diabetic retinopathy (DR) is the leading cause of blindness
and visual impairment in adults of working age in developed
countries, with an increase in affected individuals predicted
[1].
For DR, multiple funduscopic abnormalities of the retinal
vasculature and foveal avascular zone (FAZ) have been de-
scribed [2]. Studies have found that the maximum and mean
diameter and the FAZ circumference are significantly greater
in diabetic eyes compared to healthy eyes [3, 4]. Similar cor-
relations have been reported for FAZ measurements based on
fluorescein angiography (FA) [5]. The underlying pathophys-
iology of FAZ enlargement in DR is most likely related to
microinfarction within the surrounding vascular arcades
[3–6]. With the 1991 revision of the Early Treatment Diabetic
Retinopathy Study (ETDRS) grading criteria for DR, which
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emerged from the funduscopic Airlie House classification,
criteria were extended to include FA [2, 7]. Among the FA-
based grading criteria were arteriolar abnormalities, abnormal-
ities of the retinal pigment epithelium, cystoid changes, capil-
lary loss (ischemia) and leakage of fluorescein dye [7].
Today, FA and optical coherence tomography (OCT) are
commonly used imaging modalities in DR. The first report
describing FA to visualize the retinal vasculature was pub-
lished in 1930 by Kikai [8]. The method was refined through
the addition of a motion picture camera and an exciter filter by
Flocks et al. in 1959 [9]. Shortly thereafter, MacLean and
Maumenee published the first case of the use of FA to
obtain a diagnosis [10]. The first protocol of standard-
ized serial FA photography, which eventually made its
way into clinical practice, was presented by Novotny
and Alvis in 1961 [11]. However, the disadvantages of
FA soon became apparent. Studies showed that FA pho-
tographs correlated only with the anatomical arrange-
ment of large superficial retinal vessels located within
the nerve fiber layer and the ganglion cell layer, and
perfusion of deeper retinal vasculature was not visible
in FA photographs [12, 13]. Light scattering within the
retina has been suggested as the underlying cause of the
non-visibility of small retinal vessels in the ganglion
cell layer and inner nuclear layer [14]. As it is an in-
vasive imaging technique, FA has been associated with
rare but life-threatening complications such as anaphy-
laxis and cardiac arrest [15].
Optical coherence tomography (OCT), which was intro-
duced to the scientific community in 1991, revolutionized
the clinical examination of the anterior and posterior segment
of the eye [16, 17]. OCTangiography, which has recently been
developed, is a technique based on de-correlation between the
signals of two sequential OCT cross-sectional scans repeated
at the same location caused by blood flow [18–25]. Spaide
et al. demonstrated in 2015 that OCT angiography could im-
age all layers of the retinal vasculature, including the deep
layers, in contrast to FA imaging [26, 27].
With regard to the age of affected individuals and the pre-
dicted increase of DR in the population, early detection plays a
pivotal role in the treatment of DR. With the imaging modal-
ities currently used, the deep vasculature cannot be made vis-
ible. Thus it is of great interest to determine whether OCT
angiography is able to detect differences in the superficial
and deep retinal vasculature and differences in the FAZ, and
therefore might be helpful for the early recognition and grad-
ing of DR.
This retrospective single-center study was designed to in-
vestigate the dimensions and shape of the FAZ in patients with
DR in comparison to a healthy control group, using OCT
angiography. An additional objective was to investigate dif-
ferences in FAZ configuration between the superficial and
deep vascular layers.
Material and methods
Adults with healthy eyes and patients with DRwere evaluated
with OCT angiography. Healthy eyes and patients with DR
were selected and age-matched. DR was diagnosed in all pa-
tients by indirect slit-lamp funduscopy with pupil-dilatation,
digital color fundus photography (CFP) and FA and graded
according to the ETDRS classification.
In accordance with the tenets of the Declaration of Helsinki,
the study was reviewed and approved by the local ethics com-
mittee in Zurich. Written informed consent was collected from
all study subjects prior to investigation-related procedures.
All patients were imaged at the department of ophthalmol-
ogy of the Triemli Hospital in Zurich, Switzerland. This study
evaluated patients diagnosed with and treated for DR and
healthy adults scheduled for regular visits.
OCTangiography was performed with an Avanti RTVue XR
system (Optovue, Inc., Fremont, CA, USA). The instrument has
an A-scan rate of 70,000 scans per second, using a scan beam
centered at 840 nm, with a bandwidth of 45 nm. Each OCT
angiography volume contained 304×304 A-scans, with two
consecutive B-scans (M-B frames) captured at each fixed posi-
tion before proceeding to the next sampling location. The acqui-
sition time per volume amounted to approximately 3 s. Two
orthogonal volumes were acquired in order to perform motion
correction and to minimize motion artifacts. The OCT angiog-
raphy images are based on a split-spectrum amplitude de-
correlation algorithm (SSADA). The images are average de-
correlation values viewed perpendicularly through the thickness
(slabs) being evaluated. The images were captured with the
standard macula protocol with a resolution of 2 mm×2 mm.
For all measurements, the automated segmentation with the pre-
set settings for the superficial vascular layer and deep vascular
layer was utilized. Hereby, the upper border of the superficial
vascular layer was defined as 3 μm below the internal limiting
membrane (ILM) and the lower border as 15μmbelow the inner
plexiform layer (IPL). For the deep vascular layer, the borders
were defined as 15 μm and 70 μm below the IPL, respectively.
Additionally, standard spectral-domainOCT (SD-OCT) scans
(512 A-scans, 20°×15°) were taken of all eyes using the Heidel-
berg Spectralis® system (Heidelberg Engineering, Heidelberg,
Germany). During the visit, the current best-corrected visual acu-
ity (BCVA) and the intraocular pressure (IOP) were measured.
Furthermore, medical charts of all patients were reviewed for
basic demographics, clinical data and previous FA images
Image processing and analysis using ImageJ software (Na-
tional Institutes of Health [NIH], Bethesda, MD, USA) was
performed independently by two graders (F.F., M.P.) who
were each masked to the results of the other. The use of the
thresholding function of ImageJ to create binary images for
better contrast and the identification of erroneous auto-
segmentation planes was left to the discretion of the graders.
The integrated ImageJ line tool was used to measure the
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diameters and angles. All results were converted to microme-
ters by multiplying the measured values by 6.579 μm/pixel.
The intraclass correlation coefficient (ICC) of the graders
amounted to 0.857 (ICC 2.1) for the measurement of diame-
ters. For statistical purposes, Snellen visual acuity fractions
were transferred to ETDRS letter scores according to Gregori
et al. [28] All statistical analyses were performed using SPSS®
version 20 statistical software (IBM Corp., Armonk, NY,
USA). Since distributions were non-normal according to the
Shapiro–Wilk test, non-parametric tests were performed for
all analyses. The Mann–Whitney U test was used to test be-
tween two independent groups when the dependent variable
was either ordinal or continuous. For statistical testing of the
categorical data, Pearson's chi-square test (χ2) was used. Last-
ly, as a non-parametric measure of statistical dependence be-
tween two variables, Spearman's rho was applied.
Results
Clinical demographics
The study was carried out on a total of 54 eyes of 37 patients.
DRwas present in 29 eyes of 15 patients. A total of 25 healthy
eyes in 22 patients were matched according to age (Table 1).
The mean age was 58.58 years (standard deviation [SD]
±13.22 years) in the DR group and 60.41 years (±20.35) in the
control group. No statistically significant difference in age
was found between groups (p=0.41).
Qualitative findings
In the control group, the FAZ surrounding vascular arcades, a
circular system of capillaries, was intact in all 29 eyes, showing
either a vertical or horizontal oval-shaped symmetrical formation
without gaps, holes or interruption of the capillary network. The
maximum diameter of the FAZ in healthy eyes with a horizontal
oval-shaped FAZ was on the horizontal axis in the majority of
cases. Analogously, in eyes with a vertical oval-shaped FAZ, the
maximum diameter was typically on the vertical axis (Fig. 1).
In contrast, the DR group presented the classical features of
diabetic microangiopathy. Areas of capillary non-perfusion
(depicted on previous FA) appeared as areas of reduced capil-
lary density in OCT angiography, with a predominance in the
deep layer. Besides rarefaction of capillaries, venous beading
and loops, intraretinal microvascular abnormalities and
microaneurysms were visible in OCT angiography. Since
OCT angiography does not distinguish flow directionality,
CFP was used for veins. Interestingly, diabetic eyes often pre-
sented with a disintegrity of the vascular arcades surrounding
the FAZ, resulting in an enlargement of the FAZ. The FAZ often
appeared to be asymmetrical due to gaps, holes or interruption
of the capillary network. Consequently, in the DR group the
angle of the maximum diameter of the FAZwas usually neither
on the horizontal nor on the vertical axis (see Fig. 2).
Other clinical findings, such as retinal hemorrhages and
cystoid macular edema, reduced the de-correlation signal.
Thus, these findings caused shadowing, if present, in proxim-
ity to a vascular structure.
The angle of the maximum diameter of the FAZ
can be used to differentiate healthy eyes from eyes
with diabetic retinopathy
As mentioned previously, in healthy eyes the maximum FAZ
diameter was usually either horizontal (oval shaped FAZ) or
vertical (circular shaped FAZ). In contrast, in eyes with DR
atypical angles of the maximum FAZ diameter were common
due to the disintegrity of the surrounding vascular arcades.
As shown in Fig. 2, in healthy eyes the angle of the max-
imum FAZ diameter was either 0° (±15°) or 90° (±15°) in
72.0 % of all cases in the superficial layer. In the deep layer
a typical (either 0° [±15°] or 90° [±15°]) angle was found in
76.0 % of all healthy eyes.
On the contrary, in eyes with DR, the angle of the maxi-
mum FAZ diameter amounted only in 6.9 % of all cases either
to 0° (±15°) or 90° (±15°) in the superficial layer. In the deep
layers an angle of either 0° (±15°) or 90° (±15°) in eyes with
DR was only present in 13.8 % of all cases respectively.
Table 1 Clinical demographics






Age, years (mean±SD) 60.41±20.35 58.58±13.22
Gender, male/female, N 15/10 24/5
Mean BCVA, ETDRS 83.64±3.6 74.7±15.5
Diabetic retinopathy, N 0 29
Proliferative diabetic retinopathy 0 13
Pre-proliferative diabetic retinopathy 0 4











N number, SD standard deviation, BCVA best-corrected visual acuity,
ETDRS Early Treatment Diabetic Retinopathy Study
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Cohen's kappa was used to evaluate the angel categorization
of the two graders and there was almost perfect agreement (k=
0.889, p<0.001).
The FAZ is enlarged in eyes with diabetic retinopathy
In the superficial layer, the mean horizontal FAZ diam-
eter was significantly larger in the DR group (753 μm
±272 μm) than in the control group (573 μm ±177 μm,
p=0.029). As seen in Fig. 3b, the difference of the
mean horizontal diameter was even more pronounced
in the deep layer with a mean of 659 μm ±194 μm in
the control group and 1009 μm ±342 μm in the DR group
(p=0.001).
As shown in Fig. 3a and b, the most pronounced difference
between the control and DR groups was observed for the
maximum FAZ diameter. In the superficial layer, the
difference in maximum FAZ diameter between the control
group (661 μm ±171 μm) and DR group (953 μm ±393 μm)
was pronounced and statistically significant (p=0.008).
And in the deep layer, the difference in mean maximum
FAZ diameter between the control group (731 μm ±189 μm)













90° to max. FAZ diameter
Fig. 1 The superficial and deep
FAZ of a healthy eye (a, b) and an
eye with moderate non-
proliferative diabetic retinopathy
(c, d). Disintegrity of the vascular
arcades with subsequent
enlargement of the FAZ (*),
microaneurysms and vascular
abnormalities (**) and of reduced
capillary density (***) can be
identified with OCT angiography
in the eye with DR (e). The size of
all images is 3 mm×3 mm. The
schematic diagram exemplifies
the different diameters, which















Maximum diameter at 0° (± 15°) or 90° (± 15°)













** (p < 0.001)
** (p < 0.001)
Fig. 2 An angle of the maximum FAZ diameter of 0° (±15°) or 90°
(±15°) was evaluated as normal. All other angles were defined as
atypical. Pearson's chi-squared test (χ2) was used for statistical testing
of the categorical data
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Enlargement of the FAZ is correlated with reduced visual
acuity
Lastly, the FAZ diameters of all patients were examined for
correlation to BCVA.
In the superficial layer, the maximum FAZ diameter and
the BCVA (Spearman’s rho=0.429, p<0.01) as well as the
diameter at 90° to the maximum FAZ diameter and the BCVA
(Spearman’s rho=0.347, p=0.01) correlated with the visual
acuity, as demonstrated in Fig. 4a and b.
Furthermore, in the deep layer, a correlation of the
FAZ diameters with BCVA was also present. Again, the
maximum FAZ diameter (Spearman’s rho = 0.490,













































































Fig. 3 The size of the FAZ diameters within the superficial layer (a) and deep layer (b). The mean values are indicated by the dots. The statistical
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Fig. 4 a The maximum FAZ diameter in the superficial layer and BCVA
(Spearman’s rho=0.527, p<0.01). b The diameter at 90° to the maximum
FAZ diameter in the superficial layer and BCVA (Spearman’s rho=0.401,
p<0.01). c The maximum FAZ diameter in the deep layer and BCVA
(Spearman’s rho=0.544, p<0.01). d The diameter at 90° to the maximum
FAZ diameter in the deep layer and BCVA (Spearman’s rho=0.373,
p<0.01)
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diameter (Spearman’s rho=0.306, p=0.025) both corre-
lated with the BCVA.
Discussion
In this study, we assessed whether OCT angiography can de-
tect changes in FAZ shape. Furthermore, the superficial and
deep vasculature surrounding the FAZ was analyzed in DR in
comparison to a healthy control group. In addition, we were
interested to know if these FAZ alterations correlate with vi-
sual acuity and can be used for early screening.
SD-OCT imaging is not able to detect changes in FAZ.
Currently, FA is the gold standard for the exact detection of
the FAZ, without the possibility to differentiate between su-
perficial and deep retinal vasculature [29].
Our data demonstrate that OCT angiography is one of the
first non-invasive imaging techniques capable of detecting
changes in the FAZ. OCT angiography data showed that in
the superficial layer of the vasculature, the mean horizontal,
vertical, maximum and the diameter at 90° to the maximum
FAZ diameter were larger in diabetic eyes than in healthy
eyes. These findings correspond to previous reports based
on funduscopy and FA [3–5]. Moreover, all of the above-
mentioned findings are more pronounced in the deep layer,
which was unresolvable with previous approaches, especially
since the anatomical information of the deep vasculature is
lost due to retinal light scattering in FA [14]. Therefore OCT
angiography might be a better tool in detecting early FAZ
changes in DR compared to FA.
The disintegrity of the vascular arcades not only enlarges
the maximum FAZ diameter but also alters the angle of the
maximum FAZ diameter [3, 4]. Typically, in healthy eyes, the
maximum FAZ diameter was found to be either horizontal
(oval shaped FAZ) or vertical (circular shaped FAZ). Angles
outside 0° (±15°) or 90° (±15°) were almost exclusively found
in diabetic eyes. This observation is of particular importance,
as this technique offers an alternative to automated screening.
Why capillary loss tends to begin on the above-described an-
gles is unknown.
Ad hoc analysis indicates that in the superficial layer, the
calculated sensitivity and specificity of this diagnostic ap-
proach would be 93.10 % (95 % confidence interval [CI]:
77.19–98.95 %) and 72.00 % (95 % CI: 50.61–87.88 %),
and in the deep layer, 86.21 % (95 % CI: 68.32–96.03 %)
and 76.00 % 95 % (CI: 54.87–90.58 %), respectively. Espe-
cially in conjunction with the maximum FAZ diameter, the
sensitivity and specificity can be further improved.
The FA-based ETDRS grading criteria capillary loss
(ischemia) and leakage of fluorescein dye [7] are of particular
relevance for clinical practice [6, 30]. Focal photocoagulation,
a treatment modality for diabetic macular edema (dME), tar-
gets macroaneurysms and microaneurysms with leakage in
FA [30]. OCT angiography does not directly depict leakage,
and thus does not provide information on blood–retina barrier
integrity [26]. However, we found that the overlay of SD-
OCT-derived retinal thickness mapping and OCTangiography
may help to identify microaneurysms with leakage through
local thickness maxima. Hence, OCT angiography might be
applicable as a diagnostic tool for planning focal photocoag-
ulation of microaneurysms with leakage [30]. Further research
is needed to support this contention.
Correlation of FAZ dimensions with BCVA was found to
be statistically significant, which is in line with previous fun-
duscopic and FA reports [3–5]. Nevertheless, FAZ dimensions
may not be suitable for predicting BCVA, because of substan-
tial inter-individual variance in dimensions. For instance, one
diabetic eye presented with a horizontal FAZ diameter of
1323 μm and a BCVA of 35 ETDRS letters, while another
diabetic eye had a BCVA of 80 despite having an horizontal
FAZ diameter of 1729 μm. This inter-individual variance
might be due to complex differences in foveal development,
i.e. growth in axial length after formation of the FAZ [31].
Thus, inter-individual comparison of FAZ size may not be
helpful in predicting BCVA, but OCT angiography could be
important for longitudinal assessment of FAZ diameter in in-
dividual patients and might be of help in detecting early
changes without FA [32, 33].
The results of the Diabetes Control and Complica-
tions Trial (diabetes type 1) and the United Kingdom
Prospective Diabetes Study (diabetes type 2) demon-
strated that a 'safe' lower threshold for glycated haemoglobin
(HbA1c) does not exist [34, 35]. Thus, OCT angiography of
the FAZ might be beneficial for identifying early microvascu-
lar abnormalities to determine the appropriate treatment target
for patients according to their risk profile (HbA1c<48 mmol/
mol or HbA1c<53 mmol/mol). Further studies are needed to
investigate the utility of OCT angiography in eyes with no or
mild DR.
Although the use of the deep vascular layer of OCT
angiography seems promising, the automated segmenta-
tion for the superficial vascular plexus, deep vascular
plexus, outer retina and choriocapillaris was repeatedly
imprecise. Especially in patients with diabetic macular
edema (dME), which is characterized by fluid accumu-
lation in the outer plexiform layer (Henle fibre layer),
the performance of the automated segmentation of the
deep vascular layer is suboptimal. The default definition
of the borders of the deep layer result in a fixed slab
thickness of 55 μm. Thus, in these patients, the outer
vasculature of the deep vascular layer is regularly out-
side the slab. As a result, the examiner must use the
manual Z-axis fly-through in these patients.
Furthermore, the instrument requires long fixation on a
blue fixation light. Patients with low visual acuity were often
especially unable to do so.
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Limitations
The small sample size and the retrospective nature of the study
are limitations worth noting. Due to the retrospective nature of
the data and the novelty of the technique, the composition of
the DR group was heterogeneous (including patients with
mild, moderate, severe NPDR and PDR). Because of the ret-
rospective study design, image analysis was not standardized.
Further prospective research will be required to confirm our
observations.
Conclusion
OCT angiography is capable of imaging the two major layers
of the retinal vasculature without dye injection [26, 27]. Our
data show that OCTangiography was able to detect changes in
the different retinal layers and in the shape of the FAZ. Since
vascular abnormalities are more pronounced in the deep layer,
we believe that OCT angiography may be superior to FA for
the early detection of DR and for the evaluation of the FAZ in
DR. Further studies are needed to evaluate differences in FAZ
OCT angiography findings for specified subtypes of DR and
other retinal vasculopathies.
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